Business Description
Biostax Corp
NAICS : 325412
SIC : 2834
ISIN : US45252A3059
Description
Biostax Corp is a biotechnology company utilizing the Biostax Development Engine, is a developer and marketer of pharmaceutical, biotechnology and MedTech products that have a well-defined path to market. The company is focused on driving the development and commercialization of proprietary mechanisms to prevent, intercept and improve these diseases at affordable cost. It is a therapeutic and health tech agnostic, constantly seeking assets with low acquisition costs and high growth opportunities having significant clinical and commercial potential.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
12-1 Month Momentum % | -50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BTAX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biostax Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.024 | ||
| Beta | 2.2973 | ||
| 3-Year Sharpe Ratio | -1.3 | ||
| 3-Year Sortino Ratio | -1.42 | ||
| Volatility % | 50 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | -50 | ||
| 52-Week Range ($) | 0.0001 - 0.0002 | ||
| Shares Outstanding (Mil) | 78.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biostax Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biostax Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 137 days | ||
| Second quarter earnings results for 2026 | 2026-08-03 | In 35 days | ||
| First quarter earnings results for 2026 | 2026-07-06 | In 7 days | ||
| Annual report for 2025 | 2026-06-29 | 0.00 (+0.00%) | ||
| General meeting for 2025 | 2026-06-29 | 0.00 (+0.00%) | ||
| Third quarter earnings results for 2024 | 2025-04-11 | 0.00 (+0.00%) | ||
| Second quarter earnings results for 2024 | 2024-08-19 | 0.08 (-14.29%) | ||
| 0.001:1 Stock Split | 2021-05-06 | 13.20 (+0.00%) | ||
| 0.001:1 Stock Split | 2012-02-27 | 9,000.00 (+0.00%) |
Show
Entries
Biostax Corp Frequently Asked Questions
What is Biostax Corp(BTAX)'s stock price today?
The current price of BTAX is $0.00. The 52 week high of BTAX is $0.00 and 52 week low is $0.00.
When is next earnings date of Biostax Corp(BTAX)?
The next earnings date of Biostax Corp(BTAX) is 2026-07-06 Est..
Does Biostax Corp(BTAX) pay dividends? If so, how much?
Biostax Corp(BTAX) does not pay dividend.
Guru Commentaries on OTCPK:BTAX
No articles.
Press Release
Articles on Biostax Corp
No articles.